This study confirms the importance of the CRP level prior to therapy implementation (p = 0.001) and shows how statistically significant it is for inflammation in ROP (p > 0.05), which is also confirmed by Singh et al. [46]. The gene discussed is CRP; the disease is retinopathy of prematurity.